Cargando…

Intracoronary versus Intravenous Administration of Abciximab in Patients with Acute Coronary Syndrome: A Meta-Analysis

BACKGROUND: Abciximab is a widely used adjunctive therapy for acute coronary syndrome (ACS). However, the effect of intracoronary (IC) administration of abciximab on cardiovascular events remains unclear when compared with intravenous (IV) therapy. METHODOLOGY AND PRINCIPAL FINDINGS: We systematical...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Jie-Ning, Diao, Shu, Tang, Yuan-Jun, Hou, An-Ji, Yuan, Hai-Bo, Zheng, Yan, Zhou, Yu-Hao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3585408/ https://www.ncbi.nlm.nih.gov/pubmed/23469144 http://dx.doi.org/10.1371/journal.pone.0058077

Ejemplares similares

The Optimal Route of Administration of the Glycoprotein IIb/IIIa Receptor Antagonist Abciximab During Percutaneous Coronary Intervention; Intravenous Versus Intracoronary
por: Iversen, Allan, et al.
Publicado: (2008)

Comparison between Intracoronary Abciximab and Intravenous Eptifibatide Administration during Primary Percutaneous Coronary Intervention of Acute ST-Segment Elevation Myocardial Infarction
por: Namazi, Mohammad Hasan, et al.
Publicado: (2013)

Complications of intracoronary abciximab bolus-only versus standard protocol during percutaneous coronary intervention in acute coronary syndrome
por: Shakoor, Muhammad Tariq, et al.
Publicado: (2014)

Intracoronary versus intravenous abciximab in ST-segment elevation myocardial infarction: rationale and design of the CICERO trial in patients undergoing primary percutaneous coronary intervention with thrombus aspiration
por: Gu, Youlan L, et al.
Publicado: (2009)

Effects of intracoronary antithrombotics on ventricular function: A comparison of tenecteplase versus abciximab during primary percutaneous intervention in myocardial infarction
por: Morales-Ponce, Francisco J., et al.
Publicado: (2021)

Efficacy and Safety of Intracoronary versus Intravenous Administration of Tirofiban during Percutaneous Coronary Intervention for Acute Coronary Syndrome: A Meta-Analysis of Randomized Controlled Trials
por: Tang, Xiuying, et al.
Publicado: (2015)

Efficacy of Combination Treatment with Intracoronary Abciximab and Aspiration Thrombectomy on Myocardial Perfusion in Patients with ST-Segment Elevation Myocardial Infarction Undergoing Primary Coronary Stenting
por: Ahn, Sung Gyun, et al.
Publicado: (2014)

Abciximab: Abciximab-induced alveolar haemorrhage: case report
Publicado: (2021)

Comparison of myocardial reperfusion between intracoronary versus intravenous cangrelor administration in patients undergoing primary percutaneous coronary intervention
por: Muraca, Iacopo, et al.
Publicado: (2023)

Effect of Intravenous Abciximab on Coronary Flow Improvement After Re-vascularization in Primary Coronary Intervention and Short Term Impact
por: Rgeeb, Ahmed N., et al.
Publicado: (2020)

Safety and efficacy of abciximab as an adjunct to percutaneous coronary intervention
por: Vergara-Jimenez, Jennifer, et al.
Publicado: (2010)

Abciximab: a reappraisal of its use in coronary care
por: Valgimigli, Marco, et al.
Publicado: (2008)

Intracoronary Versus Intravenous Adenosine-Induced Maximal Coronary Hyperemia for Fractional Flow Reserve Measurements
por: Khashaba, Ahmed, et al.
Publicado: (2014)

Alveolar Hemorrhage during Abciximab Infusion
por: Koza, Yavuzer, et al.
Publicado: (2021)

Efficacy and Safety of Abciximab in Diabetic Patients Who Underwent Percutaneous Coronary Intervention with Thienopyridines Loading: A Meta-Analysis
por: Wu, Yihua, et al.
Publicado: (2011)

Intracoronary versus intravenous glycoprotein IIb/IIIa inhibitors during primary percutaneous coronary intervention in patients with STEMI: a systematic review and meta-analysis
por: Hahn, JongSung, et al.
Publicado: (2023)

Hemorrhagic pericarditis with cardiac tamponade after percutaneous coronary intervention associated with the use of abciximab
por: Moon, Su-Jin, et al.
Publicado: (2008)

Anti-inflammatory Effect of Abciximab-Coated Stent in a Porcine Coronary Restenosis Model
por: Hong, Young Joon, et al.
Publicado: (2007)

Duration of Hyperemia With Intracoronary Administration of Papaverine
por: Mizukami, Takuya, et al.
Publicado: (2021)

Intracoronary administration of tirofiban during percutaneous coronary intervention facilitates patients with acute coronary syndrome
por: Jia, Helei, et al.
Publicado: (2017)

Effects of abciximab on key pattern of human coronary restenosis in vitro: impact of the SI/MPL-ratio
por: Voisard, Rainer, et al.
Publicado: (2006)

COVID CORONARY: INTRACORONARY THROMBOLYTICS TO THE RESCUE
por: Randall, Morgan, et al.
Publicado: (2022)

Intralesional versus intracoronary administration of glycoprotein IIb/IIIa inhibitors during percutaneous coronary intervention in patients with acute coronary syndromes: A meta-analysis of randomized controlled trials
por: Sun, Binjie, et al.
Publicado: (2017)

Intracoronary administration of nicorandil-induced cardiac arrest during primary percutaneous coronary intervention: A case report
por: Wei, Shu-Jian, et al.
Publicado: (2019)

Early administration of abciximab reduces mortality in female patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention (from the EUROTRANSFER Registry)
por: Dziewierz, Artur, et al.
Publicado: (2012)

A case of successful primary coronary intervention for the total occlusion of left main stem with the aid of abciximab.
por: Jeong, M. H., et al.
Publicado: (2001)

Bilateral subconjunctival hemorrhage secondary to abciximab use: case report
por: Kul, Selim, et al.
Publicado: (2017)

Efficacy and safety of intracoronary versus intravenous tirofiban in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: A meta-analysis of randomized controlled trials
por: Tian, Rui, et al.
Publicado: (2023)

Editorial: Intracoronary Imaging Guidance for Percutaneous Coronary Interventions
por: Caiazzo, Gianluca, et al.
Publicado: (2022)

Attenuation of ischemia–reperfusion injury by intracoronary chelating agent administration
por: Han, Donghoon, et al.
Publicado: (2022)

Meta-analysis of randomized controlled trials on the efficacy and safety of intracoronary administration of tirofiban for no-reflow phenomenon
por: Qin, Tao, et al.
Publicado: (2013)

Effect of a Dual Drug-Coated Stent With Abciximab and Alpha-Lipoic Acid in a Porcine Coronary Restenosis Model
por: Lim, Kyung Seob, et al.
Publicado: (2011)

Migration of fully deployed stent after intracoronary glyceryl trinitrate administration: An unusual percutaneous coronary intervention complication
por: Celik, Murat, et al.
Publicado: (2013)

First-in-human pilot trial of combined intracoronary and intravenous mesenchymal stem cell therapy in acute myocardial infarction
por: Hsiao, Lien-Cheng, et al.
Publicado: (2022)

Quantitative Analysis of Coronary Vessels with Optimized Intracoronary CT Number
por: Komatsu, Sei, et al.
Publicado: (2014)

The role of intracoronary imaging in acute coronary syndromes: OCT in focus
por: Samir, Ahmad, et al.
Publicado: (2016)

Effect of intracoronary adenosine on ergonovine-induced vasoconstricted coronary arteries
por: Oh, Jun-Hyok, et al.
Publicado: (2020)

Intracoronary Lithoplasty in Percutaneous Treatment of Challenging Calcified Coronary Lesions
por: Marchese, Alfredo, et al.
Publicado: (2020)

Intracoronary physiology-guided percutaneous coronary intervention in patients with diabetes
por: Scarsini, Roberto, et al.
Publicado: (2023)

Evaluate Short-Term Outcomes of abciximab in ST-Segment Elevation Myocardial Infarction Patients Undergoing Percutaneous Coronary Intervention: A Meta-Analysis of Randomized Clinical Trials
por: Bai, Nan, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_goo0n10gp2i3qas3ju1vinou5b